Related Experiment Video
Updated: May 31, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Advanced topics in evidence-based urologic oncology: economic analysis
Bruce Vogel1, Scott M Gilbert, Jill Boylston Herndon
1Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL 32610, USA. bvogel@ehpr.ufl.edu
Urologic Oncology
|July 6, 2011
Summary
This review provides a framework for urologists to evaluate healthcare economic analyses. It emphasizes assessing the validity, impact, and applicability of cost-effectiveness studies for patient care decisions.
Area of Science:
- Urology
- Health Economics
- Healthcare Policy
Background:
- Urologists influence healthcare policy and technology adoption.
- Increasing healthcare costs necessitate economic evaluations of interventions.
- Economic analyses must balance benefit, harm, and cost.
Purpose of the Study:
- Introduce a framework for critically appraising economic analyses in urology.
- Provide guidance for evaluating the validity, impact, and applicability of cost-effectiveness studies.
- Utilize examples from urologic literature to illustrate the appraisal process.
Main Methods:
- Review article synthesizing principles of economic analysis appraisal.
- Framework development based on established health economic evaluation criteria.
- Application of the framework using a case study from urology.
Main Results:
- A structured approach to critically evaluate economic analyses is presented.
- Key criteria for assessing validity, impact, and applicability are outlined.
- The framework aids in informed decision-making regarding new technologies and treatments.
Conclusions:
- Urologists need robust methods to assess economic analyses for clinical and policy decisions.
- Effective appraisal of economic data supports evidence-based healthcare practices.
- This framework enhances the ability of urologists to integrate economic considerations into patient care and policy recommendations.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:25Urinary Tract Calculi VI: Surgical Management
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...